Serving Others at the Expense of Self: The Relationship Between Nonprofit CEO Compensation and Performance in Trade and Professional Associations

This paper investigates the organizational importance of relative CEO compensation in trade associations and professional societies. It is known that there is variation in how much pay is tied to performance in different subcategories of nonprofit organizations. However, instead of looking at how performance affects pay, we investigate how CEO compensation affects organization performance when CEOs are aware of their peer compensation and are able to influence their own. We hypothesized that CEOs who knowingly earn less will be associated with both greater financial and nonfinancial organizational performance. This altruistic perspective draws on theories from leadership and psychology rather than the more typical agency perspective and focuses on the alignment between CEO and stakeholders in a nonprofit setting. We find strong support for the relationship between lower relative CEO compensation and organization performance, while results for the moderating effect of organizational size are mixed

Projections for 'In Embryo' with Needless Alley Collective

Two performances on consecutive nights that evolved from improvisational workshops at Queen Mary University of London involving sound movement and visuals. The contribution by Evelyn Bennett and Christopher Rutter was with projections and light effects using an overhead projector and with audience participation in the evolution of the on stage narrative. Images were created using found objects, gels and drawings done by the audience in response to written questions and prompts during the performance. Needless Alley Collective was supported by Arts Council England and Queen Mary University of London for this project

High-Speed CMOS-Free Purely Spintronic Asynchronous Recurrent Neural Network

Neuromorphic computing systems overcome the limitations of traditional von Neumann computing architectures. These computing systems can be further improved upon by using emerging technologies that are more efficient than CMOS for neural computation. Recent research has demonstrated memristors and spintronic devices in various neural network designs boost efficiency and speed. This paper presents a biologically inspired fully spintronic neuron used in a fully spintronic Hopfield RNN. The network is used to solve tasks, and the results are compared against those of current Hopfield neuromorphic architectures which use emerging technologies

Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus)

Pigs are at risk of vomiting from medical conditions as well as the emetic side effects of drugs administered for peri-operative manipulations, but there is a lack of pharmacokinetic data for potential anti-emetic therapies, such as maropitant, in this species. The main objective of this study was to estimate plasma pharmacokinetic parameters for maropitant in pigs after a single intramuscular (IM) administration dosed at 1.0 mg/ kg. A secondary objective was to estimate pilot pharmacokinetic parameters in pigs after oral (PO) administration at 2.0 mg/kg. Maropitant was administered to six commercial pigs at a dose of 1.0 mg/kg IM. Plasma samples were collected over 72 h. After a 7-day washout period, two pigs were administered maropitant at a dose of 2.0 mg/ kg PO. Maropitant concentrations were measured via liquid chromatography/mass spectrometry (LC–MS/ MS). A non-compartmental analysis was used to derive pharmacokinetics parameters. No adverse events were noted in any of the study pigs after administration. Following single IM administration, maximum plasma concentration was estimated at 412.7 ± 132.0 ng/mL and time to maximum concentration ranged from 0.083 to 1.0 h. Elimination half-life was estimated at 6.7 ± 1.28 h, and mean residence time was 6.1 ± 1.2 h. Volume of distribution after IM administration was 15.9 L/ kg. Area under the curve was 1336 ± 132.0 h*ng/mL. The relative bioavailability of PO administration was noted to be 15.5% and 27.2% in the two pilot pigs. The maximum systemic concentration observed in the study pigs after IM administration was higher than what was observed after subcutaneous administration in dogs, cats, or rabbits. The achieved maximum concentration exceeded the concentrations for anti-emetic purposes in dogs and cats; however, a specific anti-emetic concentration is currently not known for pigs. Further research is needed into the pharmacodynam

Author Correction: A consensus-based transparency checklist.

An amendment to this paper has been published and can be accessed via a link at the top of the paper